FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1079911000202100: Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11797911000202116 Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11800821000202118 Sofosbuvir 400 mg and velpatasvir 100 mg and voxilaprevir 100 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing only sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antiviral therapeutic role false Inferred relationship Some
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Sofosbuvir (substance) true Inferred relationship Some 1
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Sofosbuvir (substance) true Inferred relationship Some 1
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Velpatasvir (substance) true Inferred relationship Some 2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Velpatasvir (substance) true Inferred relationship Some 2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Voxilaprevir (substance) true Inferred relationship Some 3
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Voxilaprevir (substance) true Inferred relationship Some 3
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 3
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start